Avalo Therapeutics is a biotechnology company in the healthcare sector on NASDAQ, led by Garry A. Neil, with a market cap of $337.3M. As of Q3 2025, 116% of shares are held by 65 institutional investors, with BVF INC/IL as the largest holder at 10.3%.
Overview of institutional ownership in AVTX as of Q3 2025 with a market cap of $167.2M
Based on market cap of $167.2M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.
Institutions with the largest positions in AVTX as of Q3 2025
| Institution | Position Value |
|---|---|
B BVF INC/IL Institution | $17.2M 0.70% of portfolio |
ORBIMED ADVISORS LLC Hedge Fund•Sector | $17.1M 0.42% of portfolio |
N Nantahala Capital Management, LLC Hedge Fund•Multi-Strategy | $15.7M 0.97% of portfolio |
Point72 Asset Management, L.P. Hedge Fund•Multi-Strategy | $13.4M 0.03% of portfolio |
Affinity Asset Advisors, LLC Hedge Fund•Long/Short | $12.8M 1.30% of portfolio |
C Caligan Partners LP Hedge Fund•Activist | $10.6M 1.47% of portfolio |
BALYASNY ASSET MANAGEMENT LLC Hedge Fund•Multi-Strategy | $10.4M 0.02% of portfolio |
SILVERARC CAPITAL MANAGEMENT, LLC Hedge Fund•Long/Short | $9.2M 1.33% of portfolio |
VANGUARD GROUP INC Institution | $8.8M 0.00% of portfolio |
RA CAPITAL MANAGEMENT, LLC Hedge Fund•Long/Short | $8.4M 0.10% of portfolio |
Institutional buying and selling activity for AVTX in Q3 2025
| Institution | Net Bought |
|---|---|
Point72 Asset Management, L.P. Hedge Fund•Multi-Strategy | +$13.4M +1.1M shares |
C Caligan Partners LP Hedge Fund•Activist | +$10.6M +833.3K shares |
BALYASNY ASSET MANAGEMENT LLC Hedge Fund•Multi-Strategy | +$10.4M +817.4K shares |
SILVERARC CAPITAL MANAGEMENT, LLC Hedge Fund•Long/Short | +$9.2M +720.9K shares |
VANGUARD GROUP INC Institution | +$6.7M +525.7K shares |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | +$6.1M +481.7K shares |
Affinity Asset Advisors, LLC Hedge Fund•Long/Short | +$5.1M +398.3K shares |
ORBIMED ADVISORS LLC Hedge Fund•Sector | +$4.9M +382.3K shares |
B BVF INC/IL Institution | +$4.2M +327.2K shares |
A ADAGE CAPITAL PARTNERS GP LLC Institution | +$3.3M +258.8K shares |
| Institution | Net Sold |
|---|---|
Deep Track Capital, LP Hedge Fund•Long/Short | −$5.4M −422.5K shares |
RA CAPITAL MANAGEMENT, LLC Hedge Fund•Long/Short | −$3.4M −270.0K shares |
Adviser Investments LLC Family Office | −$2.2M −174.5K shares |
A ADAR1 Capital Management, LLC Hedge Fund•Long/Short | −$919.4K −72.3K shares |
UBS Group AG Institution | −$489.5K −38.5K shares |
GEODE CAPITAL MANAGEMENT LLC ETF Provider | −$79.8K −6.3K shares |
NORTHERN TRUST CORP Institution | −$52.1K −4.1K shares |
B BlackRock, Inc. Institution | −$20.9K −1.6K shares |
RAYMOND JAMES FINANCIAL INC RIA/Wealth | −$5.0 −1.0 shares |
Institutions that initiated new positions or completely exited AVTX in Q3 2025
| Institution | Position Value |
|---|---|
C Caligan Partners LP Hedge Fund•Activist | $10.6M 833.3K shares |
SILVERARC CAPITAL MANAGEMENT, LLC Hedge Fund•Long/Short | $9.2M 720.9K shares |
A ADAGE CAPITAL PARTNERS GP LLC Institution | $3.3M 258.8K shares |
AMERIPRISE FINANCIAL INC Institution | $2.7M 213.6K shares |
S SUPERSTRING CAPITAL MANAGEMENT LP Hedge Fund•Long/Short | $2.4M 188.1K shares |
Ally Bridge Group LLC Hedge Fund•Sector | $2.3M 178.1K shares |
Boxer Capital Management, LLC Hedge Fund•Long/Short | $1.6M 125.0K shares |
Exome Asset Management LLC Hedge Fund•Sector | $1.3M 100.0K shares |
Patient Square Capital LP Private Equity | $1.3M 100.0K shares |
C CANTOR FITZGERALD, L. P. Institution | $1.1M 85.2K shares |
| Institution | Previous Position |
|---|---|
RAYMOND JAMES FINANCIAL INC RIA/Wealth | $5.0 1.0 shares |
Institutions with the largest Call and Put options positions in AVTX as of Q3 2025
| Institution | Position Value |
|---|---|
DLD Asset Management, LP Hedge Fund•Multi-Strategy | $673.0K 531.0 contracts |
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity | $644.4K 507.0 contracts |
| Institution | Position Value |
|---|---|
DLD Asset Management, LP Hedge Fund•Multi-Strategy | $296.6K 234.0 contracts |
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity | $172.9K 136.0 contracts |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | $138.5K 109.0 contracts |
Institutions with AVTX as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
V Velan Capital Investment Management LP Institution | 3.15% $3.4M |
S SUPERSTRING CAPITAL MANAGEMENT LP Hedge Fund•Long/Short | 2.36% $2.4M |
Ally Bridge Group LLC Hedge Fund•Sector | 1.90% $2.3M |
C Caligan Partners LP Hedge Fund•Activist | 1.47% $10.6M |
SILVERARC CAPITAL MANAGEMENT, LLC Hedge Fund•Long/Short | 1.33% $9.2M |
Affinity Asset Advisors, LLC Hedge Fund•Long/Short | 1.30% $12.8M |
N Nantahala Capital Management, LLC Hedge Fund•Multi-Strategy | 0.97% $15.7M |
Exome Asset Management LLC Hedge Fund•Sector | 0.86% $1.3M |
B BVF INC/IL Institution | 0.70% $17.2M |
Boxer Capital Management, LLC Hedge Fund•Long/Short | 0.52% $1.6M |
Discover hedge funds investing in AVTX

| Top Holding | Sector | Market Value | Weight |
|---|---|---|---|
Biotechnology Healthcare | $20.4M | 17.12% | |
Biotechnology Healthcare | $15.0M | 12.54% | |
Biotechnology Healthcare | $12.1M | 10.13% |
We use cookies for analytics. See our Privacy and Cookie Policy.